Atorvastatin recall may affect hundreds of thousands of patients, and reflects FDA’s troubles

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October 2025 about an extensive recall of thousands of bottles of atorvastatin, the generic version of Lipitor.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup